AHA bulletin details FDA authorization extending use date of Baxter products due to IV solutions shortage

The AHA Oct. 28 issued a Special Bulletin to members informing them of the Food and Drug Administration's authorization extending the use date for certain Baxter products amid the ongoing IV solutions shortage. The authorization allows providers to use products up to 24 months after the manufacture date. See the AHA Special Bulletin for more information.